Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Liver Diseases

Free Subscription 06.12.2021 1 Ann Intern Med 1 Biochem Biophys Res Commun 1 BMC Gastroenterol 2 Br J Surg 3 Dig Dis Sci 2 Gut 3 Hepatology 1 Int J Cancer 1 J Clin Oncol 2 J Gastroenterol 1 J Hepatol 1 Oncogene 3 PLoS One 4 Radiology 2 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. SEEBERG KA, Borgeraas H, Hofso D, Smastuen MC, et al
   Gastric Bypass Versus Sleeve Gastrectomy in Type 2 Diabetes: Effects on Hepatic Steatosis and Fibrosis : A Randomized Controlled Trial.
   Ann Intern Med. 2021 Nov 30. doi: 10.7326/M21-1962.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. ZHANG WW, Xue R, Mi TY, Shen XM, et al
   Propofol ameliorates acute postoperative fatigue and promotes glucagon-regulated hepatic gluconeogenesis by activating CREB/PGC-1alpha and accelerating fatty acids beta-oxidation.
   Biochem Biophys Res Commun. 2021;586:121-128.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

3. BAI R, An R, Han K, Xue M, et al
   Prognosis of liver transplantation: Does postoperative ileus matter?
   BMC Gastroenterol. 2021;21:444.
   PubMed         Abstract available
   
   

   
   Br J Surg

4. HOLMBERG M, Koppatz H, Jansson A, Hillingso JG, et al
   Secondary effects of the COVID-19 pandemic on surgical management of hepatopancreatobiliary malignancies in the Nordic capitals.
   Br J Surg. 2021 Dec 1. pii: 6447105. doi: 10.1093.
   PubMed        
   
   
5. SRINIVASAN M, Shaji Mathew J, Mallick S, Nair K, et al
   Middle hepatic vein reconstruction in adult living donor liver transplantation: a randomized clinical trial.
   Br J Surg. 2021 Nov 25. pii: 6439950. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. ABDU B, Akolkar S, Picking C, Boura J, et al
   Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
   Dig Dis Sci. 2021;66:4035-4045.
   PubMed         Abstract available
   
   
7. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
   A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
   Dig Dis Sci. 2021;66:4046-4057.
   PubMed         Abstract available
   
   
8. MANKA PP, Kaya E, Canbay A, Syn WK, et al
   A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
   Dig Dis Sci. 2021;66:3676-3688.
   PubMed         Abstract available
   
   

   
   Gut

9. WANG X, He Y, Mackowiak B, Gao B, et al
   MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
   Gut. 2021;70:784-795.
   PubMed         Abstract available
   
   
10. ZHANG X, Coker OO, Chu ES, Fu K, et al
    Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Gut. 2021;70:761-774.
    PubMed         Abstract available
    
    

    
    Hepatology

11. KAWAI H, Osawa Y, Matsuda M, Tsunoda T, et al
    Sphingosine-1-phosphate promotes tumor development and liver fibrosis in mouse model of congestive hepatopathy.
    Hepatology. 2021 Dec 2. doi: 10.1002/hep.32256.
    PubMed         Abstract available
    
    
12. 
    2021 Hepatology Referees (Volumes 73 and 74).
    Hepatology. 2021;74:3565-3569.
    PubMed        
    
    
13. CODISPODO G, Brown RS Jr, Hans A, Roccaro G, et al
    Hepatology Highlights.
    Hepatology. 2021;74:2931-2934.
    PubMed        
    
    

    
    Int J Cancer

14. STEPIEN M, Lopez-Nogueroles M, Lahoz A, Kuhn T, et al
    Pre-diagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
    Int J Cancer. 2021 Nov 29. doi: 10.1002/ijc.33885.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

15. SALEM R
    Hepatic Arterial Infusion Chemotherapy for Large Hepatocellular Carcinoma: Ready for Prime Time?
    J Clin Oncol. 2021 Dec 2:JCO2102392. doi: 10.1200/JCO.21.02392.
    PubMed        
    
    

    
    J Gastroenterol

16. GARCIA-VILLARREAL L, Hernandez-Ortega A, Sanchez-Monteagudo A, Pena-Quintana L, et al
    Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity.
    J Gastroenterol. 2021;56:78-89.
    PubMed         Abstract available
    
    
17. JIANG L, Starkel P, Fan JG, Fouts DE, et al
    The gut mycobiome: a novel player in chronic liver diseases.
    J Gastroenterol. 2021;56:1-11.
    PubMed         Abstract available
    
    

    
    J Hepatol

18. CABIBBO G, Singal AG
    The quest for precision oncology with immune checkpoint inhibitors and hepatocellular carcinoma.
    J Hepatol. 2021 Nov 26. pii: S0168-8278(21)02226.
    PubMed        
    
    

    
    Oncogene

19. SUN L, Xi S, Zhou Z, Zhang F, et al
    Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02130.
    PubMed         Abstract available
    
    

    
    PLoS One

20. KOO DJ, Lee MY, Jung I, Moon SJ, et al
    Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
    PLoS One. 2021;16:e0255535.
    PubMed         Abstract available
    
    
21. WU PS, Hsieh YC, Lee KC, Huang YH, et al
    Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
    PLoS One. 2021;16:e0258589.
    PubMed         Abstract available
    
    
22. TRAN BV, Ujita K, Taketomi-Takahashi A, Hirasawa H, et al
    Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    PLoS One. 2021;16:e0255768.
    PubMed         Abstract available
    
    

    
    Radiology

23. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    PubMed         Abstract available
    
    
24. LOCKHART ME
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.
    PubMed        
    
    
25. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    PubMed         Abstract available
    
    
26. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    PubMed         Abstract available
    
    

    
    Transplant Proc

27. JUSTO I, Marcacuzco A, Caso O, Garcia-Conde M, et al
    Validation of McCluskey Index for Massive Blood Transfusion Prediction in Liver Transplantation.
    Transplant Proc. 2021 Sep 28. pii: S0041-1345(21)00617.
    PubMed         Abstract available
    
    
28. SAMPANI E, Kasimatis E, Memmos E, Dimitriadis C, et al
    Transient Hyperphosphatasemia in an Adolescent and an Adult Renal Transplant Patient.
    Transplant Proc. 2021 Sep 27. pii: S0041-1345(21)00577.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: